< Back to latest news & events

Event

IP Seminar – Practical Tips to Maximise Success in EPO Oppositions and Appeals – Basel

January 2019

Event date: 16th January 2019

HGF are hosting a seminar on practical tips to maximise success in EPO oppositions and appeals at Der Teufelhof Basel on Wednesday 16th January at 6:00pm.

The opposition procedure of the European Patent Office (EPO) provides a very cost-efficient way to challenge patents granted by the EPO.  However, securing a successful outcome requires careful planning and creative thinking to effectively deal with issues that can arise in the heat of a hearing.

Partner, Gareth Probert and Patent Director, Joanna Deas will provide an overview of the opposition and appeal process and what you can expect if somebody opposes one of your patents or if you want to attack a patent of one of your competitors.  They will focus on the practical side of handling an opposition and share with you their tips and advice based on their experiences of handling more than 200 opposition and appeals.

They will also explore how some of the recent changes to the opposition procedure introduced by the EPO could influence your opposition strategy. Looking to the future, they will also discuss what you need to do now ready for when your cases are handled by the modernised Boards of Appeal as radical changes are introduced in 2019.

We hope the seminar will be of interest to innovator companies with patents as well as patent professionals.

The seminar is free to attend. To register please contact Liz Davies or call +44 (0)113 233 0189.

Gareth Probert, Partner and Head of HGF Nottingham

Gareth is an Opposition and Appeal specialist and is very experienced at representing clients in proceedings at all levels of the European Patent Office. He has achieved many successes in high value and business-critical oppositions, often working in conjunction with parallel national litigation. Gareth and his team organise mock hearings in preparation for significant cases. He focusses on medical technology, pharmaceutical and life sciences cases, and also has considerable experience in the FMCG and food sectors.

Joanna Deas, Patent Director

Joanna is a European Patent Attorney and is based in HGF’s office in Nottingham.

Joanna specialises in representing clients at EPO Opposition and Appeal hearings, and regularly attends hearings in Munich and The Hague. Joanna has particular expertise in medical technologies such as medical devices and processes, and her practice also includes working in other areas such as chemistry, formulations, polymers and pharmaceuticals. She been responsible for a number of high profile cases for a well-known FMCG company. She has also been involved in important mock hearings for several clients.

Latest updates

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article